Effects of centrally injected GLP-1 in various experimental models of gastric mucosal damage

Isbil-Buyukcoskun N., Gulec G.

PEPTIDES, cilt.25, sa.7, ss.1179-1183, 2004 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 25 Sayı: 7
  • Basım Tarihi: 2004
  • Doi Numarası: 10.1016/j.peptides.2004.05.001
  • Dergi Adı: PEPTIDES
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.1179-1183
  • Anahtar Kelimeler: GLP-1, gastric mucosal damage, i.c.v., GLUCAGON-LIKE PEPTIDE-1, ARTERIAL-BLOOD-PRESSURE, ACID-SECRETION, BINDING-SITES, RATS, BRAIN, AMIDE, EXPRESSION, ETHANOL, ULCERS
  • Bursa Uludağ Üniversitesi Adresli: Evet

Özet

Glucagon-like peptide-1 (GLP-1) is accepted to be a peptide involved in the central regulation of gastrointestinal function, but its potential gastroprotective effect is not clear. The aim of this study was to investigate whether intracerebroventricularly injected GLP-1 has protective effects on gastric mucosal lesions induced by several models, and if yes, whether these effects are due to the gastric antisecretory effect of the peptide. GLP-1 which was injected in three different doses (1, 10, 100 ng/10 mul; i.c.v.) to conscious rats prevented the mucosal lesions induced by reserpine and ethanol, but did not prevent the gastric mucosal lesions induced by pyloric ligation. In addition, 1 ng/10 mul dose of centrally injected GLP-1 inhibited gastric acid secretion in pylorus-ligated rats. As a result, we conclude that intracerebroventricularly injected GLP-1 may play a role in the prevention of gastric mucosal lesions induced by certain experimental models and this gastroprotective effect may be independent from its antisecretory effect. (C) 2004 Elsevier Inc. All rights reserved.